Adhesion molecules in cancer of the head and neck: Role of dysadherin

Journal of B.U.ON.

Volumn 16, Issue 4, 2011, Pages 609-612

  Giotakis, I ^a   Chrysovergis, Aristeidis ^a   Georgolios, A ^a   Giotakis, E ^a   Manolopoulos, L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adhesion molecules; Dysadherin; E cadherin; Head and neck cancer

Indexed keywords

CELL ADHESION MOLECULE; DYSADHERIN; UVOMORULIN;

CANCER DIAGNOSIS; DISEASE COURSE; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; LIP CANCER; METASTASIS; MOLECULARLY TARGETED THERAPY; MOUTH CANCER; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SQUAMOUS CELL CARCINOMA; THYROID CANCER; TONGUE CANCER; TUMOR GROWTH;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL ADHESION MOLECULES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS;

EID: 84855441865     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198: 11-26. (Pubitemid 24159061)
2. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339. (Pubitemid 28373643)
3. Oda T, Kanai Y, Oyama T et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A 1994; 91: 1858-1862. (Pubitemid 24080305)
4. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ. E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 1994; 107(Pt 12): 3615-3621.
5. Nagaruchi A, Ishihara S, Tsukita S. The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin-alpha catenin fusion molecules. J Cell Biol 1994; 127: 235-245. (Pubitemid 24307670)
6. Knudsen KA, Soler AP, Johnson KR, Wheelock MJ. Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol 1995; 130: 67-77.
7. Richards FM, McKee SA, Rajpar MH et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999; 8: 607-610. (Pubitemid 29139974)
8. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci U S A 2002; 99: 365-370. (Pubitemid 34060368)
9. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004; 31: 726-733. (Pubitemid 39602678)
10. Sanderson RJ, Montague ML. Surgical management of head and neck malignancy. Surgeon 2004; 2: 7-14. (Pubitemid 38219599)
11. Cortesina G, Bussi M, Carlevato MT et al. Significance of adhesion molecules as biological prognostic factors in locally advanced laryngeal squamous cell carcinomas. Acta Otolaryngol 1996; 116: 350-352. (Pubitemid 26127728)
12. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001; 23: 147-159. (Pubitemid 32060666)
13. Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2002; 112: 1970-1974. (Pubitemid 35283457)
14. Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res 2003; 9: 5055-5067. (Pubitemid 37413553)
15. Juliano RL, Varner JA. Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 1993; 5: 812-818.
16. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 1999; 222: 124-138.
17. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003; 20: 203-213. (Pubitemid 36513225)
18. Maurizi M, Scambia G, Benedetti Panici P et al. EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer 1992; 52: 862-866. (Pubitemid 23009499)
19. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993; 53: 3579-3584. (Pubitemid 23229640)
20. Pignataro L, Pruneri G, Carboni N et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 1998; 16: 3069-3077. (Pubitemid 28417428)
21. Lubarski I, Pihakaski-Maunsbach K, Karlish SJ, Maunsbach AB, Garty H. Interaction with the Na, K-ATPase and tissue distribution of FXYD5 (related to ion channel). J Biol Chem 2005; 280: 37717-37724. (Pubitemid 41642380)
22. Kyzas PA, Stefanou D, Batistatou A et al. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006; 30: 185-193.
23. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in tongue cancer immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 2004; 12: 323-328. (Pubitemid 39602071)
24. Sato H, Ino Y, Miura A et al. Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 4407-4412. (Pubitemid 37153750)
25. Nishizawa A, Nakanishi Y, Yoshimura K et al. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer 2005; 103: 1693-1700. (Pubitemid 40490031)
26. Bryne M, Boysen M, Alfsen CG et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998; 18: 4757-4764. (Pubitemid 29042056)
27. Gupta A, Deshpande CG, Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer 2003; 97: 2341-2347. (Pubitemid 36444081)
28. Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 2005; 205: 349-358. (Pubitemid 40253925)
29. Bosch FX, Andl C, Abel U, Kartenbeck J. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer 2005; 114: 779-790. (Pubitemid 40344439)
30. Chang HW, Chow V, Lam KY, Wei WI, Yuen A. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 2002; 94: 386-392. (Pubitemid 34081367)
31. Franchi A, Gallo O, Boddi V, Santucci M. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 1996; 2: 1801-1808. (Pubitemid 26356368)
32. Kawano T, Nakamura Y, Yanoma S et al. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 2004; 31: 35-41. (Pubitemid 38369373)
33. Lim SC, Zhang S, Ishii G et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 2004; 10: 166-172. (Pubitemid 38114175)
34. Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 2003; 13: 521-527. (Pubitemid 36850125)
35. Aoki S, Nakanishi Y, Akimoto S et al. Prognostic significance of laminin-5 gamma2 chain expression in colorectal carcinoma: immunohistochemical analysis of 103 cases. Dis Colon Rectum 2002; 45: 1520-1527. (Pubitemid 35345879)
36. Shimamura T, Sakamoto M, Ino Y et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. J Clin Oncol 2003; 21: 659-667. (Pubitemid 46621900)
37. Tamura M, Ohta Y, Tsunezuka Y et al. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 130: 740-745. (Pubitemid 41265713)